The group’s principle activity is to provide non-invasive diagnostic products for precise clinical management of cancer, initially focusing on cancer survivors. The group’s products are used for cancer disease, tumor growth and tumor angiogenesis. The group’s products include Triage Monitoring Assay(TM), Interval Monitoring Assay(TM), and Stratification Assay(TM). The group operates from United States.
